Highbridge Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Highbridge Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,010,000	Closed	-$10.2M	–	470
2018 Q3	$10.2M	Hold	1,010,000	–	–	0.24%	113
2018 Q2	$10.1M	Hold	1,010,000	–	–	0.2%	132
2018 Q1	$10.1M	Hold	1,010,000	–	–	0.16%	146
2017 Q4	$10.1M	Hold	1,010,000	–	–	0.18%	156
2017 Q3	$10.1M	Buy	+1,010,000	New	+$10M	0.15%	171

Highbridge Capital Management's ORGO Position: Q4 2018 in Review

Highbridge Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,010,000 shares — an estimated $10.2M sold.

Highbridge Capital Management first reported a position in ORGO in Q3 2017 and held it in 5 quarters. The position peaked at $10.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Highbridge Capital Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 1,010,000 Organogenesis Holdings shares in Q4 2018, an estimated $10.2M.
Highbridge Capital Management first reported a position in Organogenesis Holdings in Q3 2017 and held it in 5 quarters.
Highbridge Capital Management's Organogenesis Holdings position peaked at $10.2M in Q3 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.